Beta Drugs Ltd
NSE: BETA BSE: 535022
₹1394.40
(-1.59%)
Wed, 22 Apr 2026, 02:34 am
Market Cap14.08B
PE Ratio33.59
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KBeta Drugs Cashflow
| Particulars | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deprecation and amortization | -953.00K | -837.00K | -982.00K | -12.39M | -12.38M | -18.51M | -28.46M | -37.63M | -68.78M | -72.59M | -104.14M | -97.82M | -125.14M |
| Accumulated depreciation, total | -3.39M | -4.23M | -5.21M | -17.61M | -30.17M | -48.68M | -77.10M | -144.61M | -209.79M | -267.63M | -357.15M | -432.98M | -546.12M |
| Cash from operating activities | -1.13M | 1.27M | 13.67M | -9.86M | 39.46M | 163.01M | -10.83M | 60.70M | 165.15M | 281.80M | 216.31M | 291.94M | 342.65M |
| Funds from operations | 1.45M | 502.00K | -118.00K | 21.82M | 64.89M | 210.94M | 94.68M | 120.29M | 204.07M | 379.52M | 413.24M | 427.71M | 532.93M |
| Net income (cash flow) | 440.00K | 217.00K | -1.14M | 11.34M | 42.69M | 67.64M | 80.40M | 94.15M | 117.24M | 248.28M | 307.19M | 364.37M | 424.19M |
| Depreciation & amortization (cash flow) | 953.00K | 837.00K | 982.00K | 12.39M | 12.38M | 18.51M | 28.42M | 37.59M | 68.74M | 72.54M | 104.10M | 97.82M | 125.14M |
| Depreciation/depletion | 953.00K | 837.00K | 982.00K | 12.39M | 12.38M | 18.51M | 28.42M | 37.59M | 66.81M | — | 99.64M | 90.84M | 113.58M |
| Amortization | 0 | 0 | 0 | 0 | 0 | 0 | — | — | 1.93M | — | 4.46M | 6.98M | 11.57M |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | 60.00K | -553.00K | 42.00K | -1.91M | 0 | 124.08M | -12.80M | -37.02M | -24.17M | -36.03M | -101.42M | -157.65M | -207.60M |
| Changes in working capital | -2.58M | 765.00K | 13.79M | -31.68M | -25.44M | -47.93M | -105.50M | -59.59M | -38.93M | -97.72M | -196.94M | -135.77M | -190.28M |
| Cash from investing activities | -347.00K | 0 | -57.08M | -23.22M | -20.28M | -110.00M | -210.20M | -152.98M | -61.82M | -222.06M | -197.32M | -150.56M | -408.28M |
| Capital expenditures | -347.00K | 0 | -57.08M | -23.22M | -20.28M | -82.78M | -206.68M | -152.98M | -57.56M | -194.28M | -182.12M | -116.16M | -368.59M |
| Capital expenditures - fixed assets | -347.00K | 0 | -57.08M | -23.22M | -20.28M | -82.78M | -206.68M | -152.98M | -57.56M | -194.28M | -182.12M | -116.16M | -368.59M |
| Capital expenditures - other assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | — | 0 | 0 | 0 |
| Cash from financing activities | 1.48M | -1.31M | 43.92M | 33.79M | -19.02M | 64.61M | 134.98M | 113.13M | -52.94M | 9.26M | -587.00K | -46.70M | 1.25B |
| Free cash flow | -1.48M | 1.27M | -43.41M | -33.07M | 19.18M | 80.23M | -217.51M | -92.28M | 107.59M | 87.53M | 34.19M | 175.78M | -25.93M |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800